ImportRefusal LogoImportRefusal

Glaxo De Mexico S.A. De C.V.

⚠️ Moderate Risk

FEI: 3000251595 • Huipulco Mexico • MEXICO

FEI

FEI Number

3000251595

📍

Location

Huipulco Mexico

🇲🇽

Country

MEXICO
🏢

Address

Calz. Mexico-Xochimilco 4900, , Huipulco Mexico, , Mexico

Moderate Risk

FDA Import Risk Assessment

31.8
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
1
Unique Violations
6/17/2002
Latest Refusal
4/8/2002
Earliest Refusal

Score Breakdown

Violation Severity
50.0×40%
Refusal Volume
25.9×30%
Recency
0.0×20%
Frequency
40.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

Refusal History

DateProductViolationsDivision
6/17/2002
64HDL99EXPECTORANT N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)
6/17/2002
64HDL99EXPECTORANT N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)
6/17/2002
64HDL99EXPECTORANT N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)
4/8/2002
64HDL99EXPECTORANT N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)

Frequently Asked Questions

What is Glaxo De Mexico S.A. De C.V.'s FDA import refusal history?

Glaxo De Mexico S.A. De C.V. (FEI: 3000251595) has 4 FDA import refusal record(s) in our database, spanning from 4/8/2002 to 6/17/2002.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxo De Mexico S.A. De C.V.'s FEI number is 3000251595.

What types of violations has Glaxo De Mexico S.A. De C.V. received?

Glaxo De Mexico S.A. De C.V. has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Glaxo De Mexico S.A. De C.V. come from?

All FDA import refusal data for Glaxo De Mexico S.A. De C.V. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.